Now accepting Telehealth appointments. Schedule a virtual visit.
Skip to main content

Viveve Supports the FDA's Stance on the Importance of Patient Safety

Viveve Supports the FDA's Stance on the Importance of Patient Safety

In response to the recent safety warnings released by the FDA, Viveve released the below statement outlining the company’s support of patient safety and evidence‐based medicine:

To: Our Providers & Patients:
Given the FDA’s recent actions against certain companies marketing devices for vaginal rejuvenation procedures, we wanted to provide a response regarding the demonstrated safety and efficacy of our CMRF (cryogen‐cooled monopolar RF) technology. Importantly, Viveve was NOT one of the seven companies included in the FDA vaginal rejuvenation safety statement and has NOT received a warning letter.
The company views the FDA statement as a positive for the industry and for Viveve since it highlights the importance of patient safety and evidence‐based medicine. Our company, and our CMRF technology platform, have been built to provide safe treatments with proven clinical benefits.
Viveve currently has regulatory approvals or clearances in over 50 countries for the treatment of vaginal laxity and/or sexual function, and in Argentina for the treatment of mild urinary incontinence. We continue to pursue additional regulatory approvals documenting the safety and efficacy of our device for the treatment of gynecological and urological conditions, as demonstrated by:

It is important to note that the FDA and other global regulatory agencies grant approvals to proceed with human clinical trials based on extensive safety testing. Viveve has completed multiple pre‐clinical studies to thoroughly characterize the effect of our CMRF treatment, which clearly demonstrated that there was no injury to vaginal and surrounding tissues.
Viveve is committed to providing safe devices for use in clinical practice backed by high‐quality, clinical data as evidenced by:

We thank you for your continuing support in our efforts to provide safe and effective treatments that address prevalent women’s intimate health conditions.
Please feel free to contact us at if you have any further questions or concerns.
Scott Durbin Jim Atkinson
Chief Executive Officer President and Chief Business Officer

You Might Also Enjoy...

 The Dangers of High Blood Pressure

The Dangers of High Blood Pressure

High blood pressure affects nearly half of all Americans. While a common condition, the dangers of high blood pressure shouldn’t be underestimated as it can cause serious health implications if left untreated and even be life-threatening. Read on.

My Child Is Afraid of the Doctor: What Can I Do?

A doctor’s visit can be a scary experience for children. Maybe they remember getting a needle at their last appointment, or maybe it’s the fear of the unknown. It doesn’t have to be that way though. Read on.

I'm Ready to Lose Weight This Year: Can You Help?

Losing weight and getting healthier are common New Year’s resolutions for millions of Americans. While some are successful, a vast majority meet short-term goals, but end up regaining the weight and then some. What's the answer? Read on.
What Does Transitional Care Management Involve?

What Does Transitional Care Management Involve?

Returning home after a hospital, nursing home, or inpatient care facility stay can be exciting and nerve-wracking. Figuring out medications and coordinating follow-up services can be confusing, but transitional care management can help.
Helping Your Teen Navigate Depression

Helping Your Teen Navigate Depression

Depression is a leading cause of disability worldwide regardless of age. When it affects your teen, do you know what to look for and how to help your child? Read on to learn more.